Two Japanese firms to buy 86% stake in Eu Yan Sang


Eu Yan Sang operates over 170 retail outlets in China, Hong Kong, Macau, Malaysia and Singapore. — The Straits Times

SINGAPORE: Two Japanese firms are providing and outlay of US$594mil to buy out local traditional Chinese medicine maker Eu Yan Sang.

Japanese trading house Mitsui & Co announced on April 4 that a special purpose entity it has set up with Rohto Pharmaceutical will buy around 86% of Eu Yan Sang from Righteous Crane Holding.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Asian currencies struggle, stocks mostly lower amid Fed rate outlook concerns
Property sector showing signs of bottoming out
Bank Islam surpasses RM4bil green financing target, well ahead of 2025 goal
Lebtech secures RM10.8mil Selangor waterworks projects
Bursa Malaysia seeks feedback on depository rules for electronic CDS statements
Southern Cable wins RM172.57mil cable supply contract
Bursa Malaysia higher at midday, boosted by year-end window dressing
China's yuan nears key threshold, set for third straight yearly loss in 2024
South Korean won drops to lowest level since March 2009; stocks ease
Cocoa, pepper continue resilient performance in 2024, positive outlook in 2025

Others Also Read